M
myTomorrows
Earlier access to innovative drugs worldwide
About myTomorrows
myTomorrows operates in the healthcare sector, focusing on bridging the gap between patients with serious diseases and BioPharma companies developing new treatments. The company serves patients, healthcare professionals, and BioPharma companies by providing a platform that facilitates patient recruitment for clinical trials, expanded access management, and Real World data collection. myTomorrows generates revenue through partnerships with BioPharma companies, offering them services that streamline the process of patient recruitment and data collection. The business model is centered on creating a connected hub that supports both patients in need of new treatment options and BioPharma companies looking to bring their innovations to market more efficiently. The market it operates in includes the global healthcare and pharmaceutical industries, with a particular focus on innovative treatments and clinical trials.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Amsterdam, Netherlands
- Employees
- 139
- Open positions
- 21
- Dealroom signal
- 86.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, StartupAmsterdam, Sustainable Development Goals, Clinical Trials, Tech for Biotech and Pharma, AI Drug Discovery
- Technology
- Big Data
- Business model
- Marketplace & ecommerce, SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Nov 2025 | $29M | $116M | Avego | ↗ |
| SERIES AOther financing | Jan 2017 | $11M | $44M | Octopus Ventures · EQT Ventures · Balderton Capital · Sofinnova Partners | ↗ |
Growth signals
Latest recorded traffic for myTomorrows is 15K monthly website visits, down 37.5% over the last three months. myTomorrows's team grew 9.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Series A2 investors entered at this stage
EQT Ventures
Octopus Ventures
Series B and later1 investor entered at this stage
Avego
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about myTomorrows on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See myTomorrows’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.